When we explain the side effects, at least a third of the patients decide not to take [finasteride].

What is a bit scary is this risk of sexual problems. When we explain the side effects, at least a third of the patients decide not to take it… [The European Medicines Agency’s finasteride investigation] grabs our attention because we need to evaluate our patients to see if they have depressive tendencies. This makes us think twice when prescribing the medication.

—Hair Loss, Hair Transplants & Hormones: The Silent Suffering of Thousands of Young People: Radio Télévision Suisse, Oct. 8, 2025